We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+7.83%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$2.92B
AUM Growth
-$349M
(-11%)
Cap. Flow
-$416M
Cap. Flow
% of AUM
-14.24%
Top 10 Holdings %
Top 10 Hldgs %
63.86%
Holding
67
New
12
Increased
7
Reduced
7
Closed
4
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$75.9M |
| 2 |
Viridian Therapeutics
VRDN
|
+$32M |
| 3 |
MBX
MBX Biosciences
MBX
|
+$26.9M |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$23.3M |
| 5 |
Relay Therapeutics
RLAY
|
+$18.7M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
+$222M |
| 2 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
+$170M |
| 3 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$153M |
| 4 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$30.5M |
| 5 |
ITOS
iTeos Therapeutics
ITOS
|
+$25M |
Sector Composition
| 1 | Healthcare | 99.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
1
DELISTED
Apellis Pharmaceuticals
APLS
| $343M | 11.74% |
11,890,843
+283,418
| +2% | +$10.5M |
|
2
AnaptysBio
ANAB
$1.65B
| $261M | 8.94% |
7,794,996
+273,972
| +4% | +$9.36M |
|
3
Crinetics Pharmaceuticals
CRNX
$8.88B
| $219M | 7.5% |
4,288,120
+132,745
| +3% | +$6.85M |
|
4
Prothena Corp
PRTA
$441M
| $194M | 6.64% |
11,584,280
| – | – |
|
|
5
Jazz Pharmaceuticals
JAZZ
$15B
| $190M | 6.51% |
1,706,469
+692,517
| +68% | +$75.9M |
|
6
Zymeworks
ZYME
$1.81B
| $169M | 5.77% |
13,437,473
| – | – |
|
7
Arvinas
ARVN
$534M
| $166M | 5.67% |
6,726,491
| – | – |
|
8
Kura Oncology
KURA
$1.01B
| $113M | 3.89% |
5,806,871
| – | – |
|
9
Xencor
XNCR
$1.11B
| $107M | 3.67% |
5,330,416
| – | – |
|
10
Tango Therapeutics
TNGX
$4.93B
| $103M | 3.52% |
13,330,736
| – | – |
|
11
Janux Therapeutics
JANX
$978M
| $66.8M | 2.29% |
1,469,818
| – | – |
|
12
CRISPR Therapeutics
CRSP
$5.06B
| $65.3M | 2.24% |
1,389,276
| – | – |
|
13
Immunome
IMNM
$2.6B
| $56.7M | 1.94% |
3,879,415
| – | – |
|
14
Neurogene
NGNE
$787M
| $53.3M | 1.83% |
1,271,342
| – | – |
|
|
CNTA
15
DELISTED
Centessa Pharmaceuticals
CNTA
| $51.5M | 1.77% |
3,223,851
-2,490,553
| -44% | -$30.5M |
|
|
16
Viridian Therapeutics
VRDN
$2.1B
| $44.6M | 1.53% |
+1,958,847
| New | +$32M |
|
17
Nuvation Bio
NUVB
$2.05B
| $44M | 1.51% |
19,209,643
| – | – |
|
|
THRD
18
DELISTED
Third Harmonic Bio
THRD
| $43.1M | 1.48% |
3,182,444
| – | – |
|
19
Vaxcyte
PCVX
$8.19B
| $40.3M | 1.38% |
352,464
+52,464
| +17% | +$4.73M |
|
|
MRSN
20
DELISTED
Mersana Therapeutics
MRSN
| $36.6M | 1.25% |
774,588
| – | – |
|
21
Oric Pharmaceuticals
ORIC
$1.15B
| $35M | 1.2% |
3,418,068
| – | – |
|
|
RNAM
22
DELISTED
Avidity Biosciences
RNAM
| $34.8M | 1.19% |
757,576
| – | – |
|
23
Edgewise Therapeutics
EWTX
$4.39B
| $33.4M | 1.14% |
1,250,385
| – | – |
|
|
MBX
24
MBX Biosciences
MBX
$2.89B
| $30.5M | 1.05% |
+1,175,809
| New | +$26.9M |
|
25
Neumora Therapeutics
NMRA
$302M
| $27.4M | 0.94% |
2,071,450
| – | – |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM